Challenges of Whole Blood Potassium Testing: Impact of Hemolysis and Potential Solutions

Formats the Html codes.FormatFix the Html to be XHtml compliantFix Write Validate that the text is XHtml compliant.Validate Proofing

Tuesday, July 30
Time: 1:45 - 2:45 p.m.
Location: Exhibit Hall Theater #1
Sponsored by Werfen

Overview

What might you be missing in your whole blood potassium results? This workshop will focus on the challenges of whole blood potassium testing and the impact of hemolysis including its prevalence. Current strategies and a new technology to detect hemolysis to mitigate risk at the point of care will also be discussed.

Moderator

Anne Winkler, MD
Vice President, Reagent Development and Medical Affairs, Werfen

Speakers

Alan Wu, PhD
Co-Core Lab Director Zuckerberg San Francisco General Hospital, Professor Laboratory Medicine and Chief, Clinical Pharmacogenomics Laboratory, University of California, San Francisco

Christopher Farnsworth, PhD, DABCC, FADLM
Associate Professor, Department of Pathology and Immunology, Medical Director of Clinical Chemistry Point-of-Care Testing Washington University School of Medicine